Filing Details
- Accession Number:
- 0001104659-20-027330
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-28 19:00:36
- Reporting Period:
- 2020-02-27
- Accepted Time:
- 2020-02-28 19:00:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1270073 | Intercept Pharmaceuticals Inc. | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493811 | Christian Weyer | C/O Intercept Pharmaceuticals, Inc. 10 Hudson Yards, Floor 37 New York NY 10001 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-27 | 357 | $85.39 | 17,480 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-02-27 | 113 | $87.62 | 17,367 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
- This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.